Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04538859

A Prospective Study of Factors Related to Exacerbation and Mortality of Non-cystic Fibrosis Bronchiectasis in Hong Kong

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Bronchiectasis is associated with repeated exacerbations which occurs at rates of 1.5-6.5 per patients per year, and are associated with an increased risk of admission and readmission to hospital, and high health care costs. In a local study carried out more than 10 years ago, idiopathic disease dominates and patients with bronchiectasis are mainly female with high hospitalization and mortality rates; 21.9 cases per 100,000 and 2.7 cases per 100,000 respectively. Moreover, exacerbation characterized by increases in symptoms requiring antibiotic treatment is associated with disease progression and significant mortality. Updated prevalence of this disease with the characteristics of etiology, clinical presentation and outcomes are needed to guide further management plan.

Conditions

Timeline

Start date
2020-08-30
Primary completion
2027-08-29
Completion
2027-08-29
First posted
2020-09-04
Last updated
2020-09-04

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04538859. Inclusion in this directory is not an endorsement.